全部分类
  • BAY 57-1293
BAY 57-1293的可视化放大

BAY 57-1293

A helicase-primase inhibitor

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

BAY 57-1293的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 5mg
    ¥550.00
    440.00
    - +
  • 10mg
    ¥762.00
    610.00
    - +
  • 25mg
    ¥1737.00
    1390.00
    - +
  • 50mg
    ¥1625.00
    1300.00
    - +
  • 100mg
    ¥2725.00
    2180.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajci6960
  • CAS: 348086-71-5
  • 别名: 普瑞利韦; AIC316; BAY 57-1293
  • 分子式: C18H18N4O3S2
  • 分子量: 402.49
  • 纯度: >98%
  • 溶解度: ≥ 13.9mg/mL in DMSO
  • 储存: Store at -20°C
  • 库存: 现货

Background

BAY 57-1293 is a potent and safe inhibitor of HSV helicase-primase with IC50 value of 12nM [1].


BAY 57-1293 displays anti-herpes activity through inhibiting the helicase-primase and affecting the viral DNA synthesis. In the in vitro viral replication assay, BAY 57-1293 shows inhibition against HSV-1 F, HSV-2 G and acyclovir-resistant HSV-1 F mutant with IC50 value of 20nM. In the plaque reduction assay and the conventional cytopathogenicity assay, BAY 57-1293 shows IC50 values of 0.01-0.02μM and 0.01-0.03μM, respectively. Besides that, BAY 57-1293 is active at an IC50 value of 10nM–30nM against all clinical isolates of HSV-1 and HSV-2. Furthermore, BAY 57-1293 is active in vivo. The oral administration of BAY 57-1293 shows 10-fold more potent than valacyclovir in a murine model of disseminated herpes infection. In a rat lethal challenge model, BAY 57-1293 exerts profound antiviral activity without toxic effects. [1, 2]

参考文献:
[1] Kleymann G, Fischer R, Betz U A K, et al. New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease. Nature medicine, 2002, 8(4): 392-398.
[2] Betz U A K, Fischer R, Kleymann G, et al. Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293. Antimicrobial agents and chemotherapy, 2002, 46(6): 1766-1772.

没有评价数据

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算